STANDARD BIOTOOLS INC. (LAB) Earnings
STANDARD BIOTOOLS INC.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Aug 5, 2026
From the latest earnings 8-K
Revenue • FY2025
$85.33M
▼ 51.1%YoY
Diluted EPS • FY2025
-$0.20
▲ 61.5%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from LAB's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $85.33M | -$74.9M | $42.54M | -$0.20 | -$82.65M | -129.2% | -51.1% |
| FY2024 | $174.43M | -$138.88M | $84.26M | -$0.52 | -$151.81M | -100.5% | +64.0% |
| FY2023 | $106.34M | -$74.66M | $50.45M | -$0.94 | -$46.12M | -72.0% | +8.6% |
| FY2022 | $97.95M | -$190.1M | — | -$2.43 | -$93.19M | -118.6% | -25.0% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 5, 2026 | 8-K (2.02) | 0001193125-26-335106EDGAR |
| May 5, 2026 | 8-K (2.02) | 0001193125-26-206395EDGAR |
| Feb 24, 2026 | 8-K (2.02) | 0001193125-26-067026EDGAR |
| Jan 30, 2026 | 8-K (2.02) | 0001104659-26-008375EDGAR |
| Jan 8, 2026 | 8-K (2.02) | 0001193125-26-006996EDGAR |
| Nov 4, 2025 | 8-K (2.02) | 0001193125-25-264693EDGAR |
| Aug 11, 2025 | 8-K (2.02) | 0000950170-25-106636EDGAR |
| May 6, 2025 | 8-K (2.02) | 0000950170-25-064439EDGAR |
Never miss a LAB filing.
Get an email when LAB files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.